In April 2026, Qingdao AMA Co., Ltd. Biochemical Equipment Co., Ltd. made appearances at both the 2026 National Academic Conference of the Chinese Society for Cell Biology (CSCB 2026) held in Hefei and the 2026 Zhangjiang Pharmaceutical Valley International Innovation Conference - Advanced Therapy Forum & Shanghai Stem Cell Industry Conference. At these two industry events, we showcased our full range of cell culture consumables and cutting-edge scaffold-free cell sheet technology, engaging in in-depth discussions with domestic and international experts, as well as new and longstanding partners, and gained a lot from these exchanges.

I. Hefei Cell Biology Conference: Basic consumables receive widespread attention, and professional services are widely recognized

From April 8th to 12th, CSCB 2026 was held in Hefei. As a high-level academic conference in the field of cell biology, the conference gathered numerous representatives from universities, research institutes, and enterprises.

During the exhibition,Qingdao AMA Co., Ltd. showcased a comprehensive product matrix, ranging from conventional cell culture dishes/plates/bottles to cutting-edge 3D organoid culture containers and confocal dedicated culture dishes, fully demonstrating the company's solid accumulation in the field of laboratory consumables. While introducing the products to the visitors, the team of Qingdao AMA Co., Ltd. provided detailed answers to practical challenges in cell culture, such as cell clustering, edge effects, and TC surface adaptation. Many imaging equipment manufacturers, university teachers and students, and distributors stopped to communicate, giving high praise to the quality and consistency of the products. Qingdao AMA's professional and patient service also won widespread recognition.

II. Zhangjiang Innovative Advanced Therapy Cells Conference: Stent-free cell sheets ignited the audience, and the roadshow received enthusiastic responses

From April 17th to 18th, the Shanghai Stem Cell Industry Conference was held at the Zhangjiang Science Hall. The conference focused on the clinical translation and industrialization path of stem cell technology, bringing together regulatory agencies, top-tier hospitals, investment institutions, and industry chain enterprises. 

During the conference, the team of Qingdao AMA Co., Ltd. listened carefully to multiple high-level thematic reports, gaining a deeper understanding of the latest developments in the field and regulatory policies. At the booth, basic consumables such as cell culture dishes/plates/bottles also attracted a large number of participants for inquiries, demonstrating the company's solid reputation in the field of conventional scientific research tools. The company's self-developed temperature-sensitive scaffold-free cell sheet technology became the focus of the booth. Many clinical experts, investors, and industry partners engaged in in-depth discussions on technical principles, animal experimental data, and clinical application prospects, expressing strong interest in collaboration.

At the sub-forum on innovation and investment in the stem cell industry, our company delivered a special report, systematically introducing the technical advantages of scaffold-free cell sheets. By utilizing temperature changes, we achieved non-destructive detachment of cell sheets, fully preserving the extracellular matrix and cell connections, with a cell survival rate of 98.65%.

The stent-free cell sheet has garnered significant attention, which is attributed to Jindian's sustained R&D investment over the years, profound accumulation of laboratory consumables spanning over three decades, and our unwavering commitment to independent innovation and alignment with the national development of regenerative medicine. The core temperature-sensitive material of this technology has been granted invention patents in both China and the United States, ensuring clear technological sovereignty and freedom from foreign patent restrictions. Animal experiments have verified the feasibility and safety of this technology in scenarios such as corneal transplantation, highlighting its clear potential for clinical translation. 

III. Looking Ahead

From the extensive attention to consumable products at the Hefei booth to the explosion of cutting-edge technologies at the Shanghai booth, Qingdao AMA Co., Ltd. is leveraging the dual-driven approach of "basic consumables + innovative technologies" to serve life science research and clinical applications in regenerative medicine.

In the future, we will continue to adhere to a market-oriented approach, survive on quality, and seek development through technology, providing high-quality products and customized services to universities, research institutes, and biopharmaceutical companies.

Thank you to every friend who visited our booth,

Thank you for the team's hard work!